Skip to main content
Contact Us
Subscribe
E-Edition
35°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by PureTech Health plc
< Previous
1
2
3
4
Next >
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)
February 27, 2023
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression
February 14, 2023
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech to Present at the SVB Securities Global Biopharma Conference
February 01, 2023
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Provides End of Year Report on Key Progress
December 22, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers
December 19, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring
December 09, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ Platform
November 30, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech to Present at Two Upcoming Investor Conferences
November 17, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech to Present at the Jefferies London Healthcare Conference
November 09, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
November 01, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech to Present at the Morgan Stanley Global Healthcare Conference
September 08, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye Pharmaceuticals
August 24, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
August 01, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate
July 14, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
July 11, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)
June 30, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia
June 28, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
Results of Annual General Meeting
June 15, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
June 14, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
June 14, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
June 06, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
May 26, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
May 24, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech to Present at the UBS Global Healthcare Conference
May 17, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
May 16, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Announces Share Buyback Program Update
May 09, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Announces Share Buyback Program of up to $50 Million
May 05, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
May 04, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
April 29, 2022
From
PureTech Health plc
Via
Business Wire
Tickers
PRTC
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.